DMBT1
DMBT1 (deleted in malignant brain tumours 1; also known as GP340 and SALSA) is a secreted glycoprotein built from scavenger receptor cysteine-rich domains. It has been linked to mucosal defence, epithelial differentiation and binding of bacteria and viral envelope proteins. Browse Assay Genie's current range of DMBT1 research reagents below, or read on for the biology behind the target.
DMBT1 is a secreted glycoprotein with a broad role at epithelial surfaces. It shows a calcium-dependent binding spectrum against both Gram-positive and Gram-negative bacteria, which suggests a role in defence against bacterial pathogens. This broad specificity may be explained by its binding to a range of poly-sulfated and poly-phosphorylated ligands. DMBT1 also inhibits cytoinvasion of S. enterica, and it binds the HIV-1 envelope protein, where it has been shown both to inhibit and to facilitate viral transmission.
Beyond host defence, DMBT1 may act as an opsonin receptor for SFTPD and SPAR in macrophage tissues, including epithelial cells lining the gastrointestinal tract. It is proposed to contribute to the mucosal defence system, cellular immune defence and epithelial differentiation, and it is required for terminal differentiation of columnar epithelial cells during early embryogenesis. It may also play a role in liver regeneration and in the fate decision of transit-amplifying ductular (oval) cells within the hepatic lineage, and it may function as a salivary binding protein in the regulation of taste sensation. DMBT1 associates with the actin cytoskeleton and is involved in its remodelling during regulated exocytosis. It interacts with pancreatic zymogens in a pH-dependent manner and may act as a Golgi cargo receptor in the regulated secretory pathway of pancreatic acinar cells.
The DMBT1 gene was originally isolated on the basis of its deletion in a medulloblastoma cell line, and loss of sequences from human chromosome 10q has been associated with cancer progression. The protein precursor contains multiple scavenger receptor cysteine-rich (SRCR) domains separated by SRCR-interspersed domains. Transcript variant 2 binds surfactant protein D independently of carbohydrate recognition, indicating that DMBT1 may not be a classical tumour suppressor but may instead mediate interactions between tumour cells and the immune system. It belongs to the DMBT1 family, and mouse and rat each have a Dmbt1 ortholog.
DMBT1 may contribute to mucosal defence and cellular immune defence, binding a broad range of Gram-positive and Gram-negative bacteria.
Deleted in a medulloblastoma cell line and proposed as a candidate tumour suppressor, DMBT1 may mediate tumour cell and immune system interaction.
DMBT1 binds the HIV-1 envelope protein and inhibits S. enterica cytoinvasion, making it relevant to studies of viral and bacterial interactions.
DMBT1 is required for columnar epithelial differentiation in early embryogenesis and may influence oval cell fate and liver regeneration.
DMBT1 is a secreted scavenger receptor cysteine-rich glycoprotein. It binds a wide range of bacteria in a calcium-dependent manner, binds the HIV-1 envelope protein, and may contribute to mucosal defence, epithelial differentiation and regulated secretion in pancreatic acinar cells.
DMBT1 stands for deleted in malignant brain tumours 1. Its aliases are GP340, Gp-340 and SALSA. The UniProt entry names it scavenger receptor cysteine-rich domain-containing protein DMBT1, and it belongs to the scavenger receptor cysteine rich domain containing gene group.
Mouse and rat both have a Dmbt1 ortholog. The gene was first isolated from a deletion in a medulloblastoma cell line, but NCBI notes it may not be a classical tumour suppressor and may instead affect tumour-immune interactions. Check the datasheet of any product for its validated reactivity.
Binding partners and related proteins in mucosal defence and innate immunity.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UGM3; product specifications from Assay Genie datasheets.